Clinical Trials in North Carolina

Showing 13341-13360 of 17,526 trials

Add Glucokinase Activator to Target A1c

NCT02405260

This trial is a multi-center, adaptive, randomized, double-blind, placebo- and active- controlled, parallel group, Phase 2 study in subjects with T2DM to evaluate the effect of TTP399 on HbA1c following administration for 6 months.

Diabetes Mellitus, Type 2

vTv Therapeutics190 participantsStarted Mar 2015

Mesa, Arizona, United States • Tuscon, Arizona, United States • Canoga Park, California, United States +17 more locations

TERMINATEDPhase 2/331 miles

Drug Study of Albuterol to Treat Acute Lung Injury

NCT00434993

Acute Respiratory Distress Syndrome (ARDS) and a lesser condition that occurs prior to ARDS, Acute Lung Injury (ALI), are medical conditions that occur when there is severe inflammation and increased fluids (edema) in both lungs, making it hard for the lungs to function properly. Patients with these conditions require treatment that includes the use of a breathing machine (ventilator). The purpose of this study is to find out whether giving albuterol (a drug commonly used in asthmatics) or not giving albuterol to patients with ALI or ARDS makes a difference in how long it takes for a patient to be able to breath without the ventilator.

Respiratory Distress Syndrome, Adult

National Heart, Lung, and Blood Institute (NHLBI)282 participantsStarted Aug 2007

Fresno, California, United States • Sacramento, California, United States • San Francisco, California, United States +37 more locations

Add Glucokinase Activator to Target A1c

Drug Study of Albuterol to Treat Acute Lung Injury

Find Trials by Condition in North Carolina

ProMRI Study of the Entovis Pacemaker System

Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study

Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

EPO906 Therapy in Patients With Prostate Cancer

Study of the Glutaminase Inhibitor CB-839 in Leukemia

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes